Rifaximin in Cirrhosis: Effects on Endotoxin and Haemostatic Indexes

Clinical trial NCT06630572 · TERMINATED

Trial details

NCT number: NCT06630572
Sponsor: University of Roma La Sapienza
Status: TERMINATED
Phase: Phase 4
Study type: INTERVENTIONAL

Liver Cirrhosis Coagulation Disorder Platelet Disorder Endotoxemia

Start date: 2021-04-03
Primary completion: 2022-04-03
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.